Nurix Therapeutics, Inc. Balance Sheet

Balance Sheet Nov2019 Nov2020 Nov2021 Nov2022 Nov2023 Nov2024
Accumulated Depreciation 11.00M13.18M14.88M
Assets
Assets 44.05M396.34M476.77M416.76M355.60M669.34M
Current Assets
Cash & Equivalents 34.82M119.36M80.51M64.47M54.63M110.00M
Receivables - Net 6.00M
Receivables - Other 7.50M0.90M1.00M4.00M5.00M
Receivables 6.90M
Prepaid Assets 1.63M5.94M9.19M9.31M7.59M9.80M
Current Assets 39.35M298.43M311.12M318.45M295.50M619.39M
Non-Current Assets
Property, Plant & Equipment (Net) 3.87M6.67M11.34M17.16M16.81M17.76M
Long-Term Investments 0.51M90.89M137.19M63.88M7.42M
Other Non-Current Assets 0.17M0.20M2.83M0.90M3.82M3.16M
Non-Current Assets 4.69M97.91M165.65M98.31M60.09M49.96M
Liabilities
Current Liabilities
Accounts Payables 1.60M3.41M6.65M5.06M6.40M11.48M
Payables 1.60M3.41M6.65M5.06M6.40M11.48M
Accumulated Expenses 4.93M8.33M14.55M22.43M24.97M37.99M
Other Accumulated Expenses 0.31M0.70M0.66M1.50M0.75M2.27M
Current Leases 3.85M5.53M7.49M8.01M
Current Taxes 0.03M0.07M0.07M
Current Deferred Revenue 9.61M32.80M41.21M37.63M48.10M38.36M
Total Current Liabilities 16.14M44.54M66.26M70.66M86.96M95.85M
Non-Current Liabilities
Non-Current Deffered Revenue 35.69M60.69M59.02M35.97M45.02M26.21M
Preferred Stock Liabilities 48.20M
Operating Leases 9.19M6.43M23.12M20.29M
Other Non-Current Liabilities 1.74M0.85M
Total Non-Current Liabilities 51.83M105.22M
Liabilities
Total Liabilities 53.57M106.07M134.47M113.06M155.10M142.35M
Shareholder's Equity
Common Equity -57.71M290.27M342.30M303.70M200.49M526.99M
Shareholder's Equity -57.71M290.27M342.30M303.70M200.49M526.99M
Liabilities and Shareholders Equity 44.05M396.34M476.77M416.76M355.60M669.34M
Retained Earnings -60.46M-103.70M-220.89M-401.25M-545.20M-738.77M
Treasury Shares 0.02M0.00M0.02M0.78M1.25M1.96M
Shares Outstanding 3.60M38.86M44.66M47.17M48.72M75.87M